Previous 10 | Next 10 |
Search all stock news releases related news releases and press releases from US and Canada Markets.
DEVON, Pa., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that Armando Anido, Chairman and Chief Executive Offic...
EDINBURG, Va., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel”) (Nasdaq: SHEN) announced second quarter 2022 financial and operating results. Second Quarter 2022 Highlights Revenue grew 8.8% to $66.0 million over the same ...
GREELEY, Colo., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Pilgrim’s [NASDAQ: PPC], a leading global food company, today announced the release of its 2021 Sustainability Report , which includes progress updates toward the organization’s 2030 goals that were announced last year. The...
– Expect to complete SER-109 Biologics License Application filing in the coming weeks – – Reported confirmatory SER-109 Phase 3 study results, including in individuals with a first recurrence of C. difficile infection – – Stre...
Worldwide Ocaliva® non-GAAP adjusted net sales in PBC of $100.4 million; U.S. net sales of $71.8 million representing 5% growth over the prior year quarter Company reissues 2022 financial guidance to reflect impact of sale of international business: Ocaliva non-GAAP adjuste...
Second-Quarter 2022 Results: -- Net Sales of $876.4 Million; Orphan Segment Net Sales Increased 13% to $841.3 Million -- -- GAAP Net Income of $61.0 Million; Adjusted EBITDA of $306.6 Million -- -- TEPEZZA ® (teprotumumab-trbw) Net Sales of $479.8 Mi...
U.S. Food and Drug Administration (FDA) Clearance of Investigational New Drug (IND) application to study GMI-1687 in Sickle Cell Disease (SCD) received in June The Company previously disclosed and will continue to update its projection of mid-year 2023 for the survival events trig...
– Record Second Quarter Revenue up 10.3% to $180.3 Million; up 13.7% on a Constant Currency Basis – – Net Income attributable to Controlling Interest of $11.1 Million, or $0.32 Per Share – – Adjusted EPS of $0.20 – ...
Ceragon Confirms Receipt of Revised Non-binding Indication of Interest from Aviat Networks PR Newswire Shareholders are Not Required to Take any Action at this Time ROSH HA 'AIN, Israel , Aug. 3, 2022 /PRNewswire/ -- Ceragon Networks Ltd...
Investment Management continues to scale, further increasing recurring earnings Second quarter operating highlights: TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (NASDAQ and TSX: CIGI) (“Colliers” or the “Company”) ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
15.98%Change Percent:
Ryanair Holdings plc American Depositary Shares each representing five Ordinary Shares Company Name:
RYAAY Stock Symbol:
NASDAQ Market:
ryanair.com Website: